IFAM
ODT

Institutional & Family Asset Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Institutional & Family Asset Management’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15
Closed -$1K – 921
2020
Q2 		$1K Sell
15
-5
-25% -$162 ﹤0.01% 826
2020
Q1 		$1K Hold
20
– – ﹤0.01% 796
2019
Q4 		$1K Hold
20
– – ﹤0.01% 841
2019
Q3 		$1K Buy
+20
New +$669 ﹤0.01% 818

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Institutional & Family Asset Management's ODT Position: Q3 2020 in Review

Institutional & Family Asset Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2020, closing a stake of 15 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in ODT in Q3 2019 and held it in 4 quarters. The position peaked at $1K in Q2 2020. 89 funds tracked by Wall St. Rank hold ODT as of Q3 2020.

  • Institutional & Family Asset Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 15 Odonate Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $1K.
  • Institutional & Family Asset Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • Institutional & Family Asset Management's Odonate Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2020.
  • 89 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Institutional & Family Asset Management's 13F filing for Q3 2020, filed 30 Oct 2020.